American Journal of Ophthalmology
Volume 150, Issue 6 , Pages 876-882.e1 , December 2010

Intravitreal Injection of Autologous Plasmin Enzyme for Macular Edema Associated with Branch Retinal Vein Occlusion

,Accepted 12 June 2010.

References 

  1. Frangieh GT, Green WR, Barraquer SE, Finkelstein D. Histopathologic study of nine branch retinal vein occlusions. Arch Ophthalmol. 1982;100(7):1132–1140
  2. Elman MJ. Thrombolytic therapy for central retinal vein occlusion: results of a pilot study. Trans Am Ophthalmol Soc. 1996;94:471–504
  3. Weiss JN. Treatment of central retinal vein occlusion by injection of tissue plasminogen activator into a retinal vein. Am J Ophthalmol. 1998;126(1):142–144
  4. Lahey JM, Fong DS, Kearney J. Intravitreal tissue plasminogen activator for acute central retinal vein occlusion. Ophthalmic Surg Lasers. 1999;30(6):427–434
  5. Glacet BA, Kuhn D, Vine AK, Oubraham H, Coscas G, Soubrane G. Treatment of recent onset central retinal vein occlusion with intravitreal tissue plasminogen activator: a pilot study. Br J Ophthalmol. 2000;84(6):609–613
  6. Murakami T, Takagi H, Kita M, et al. Intravitreal tissue plasminogen activator to treat macular edema associated with Branch retinal vein occlusion. Am J Ophthalmol. 2006;142(2):318–320
  7. Chen SN, Yang TC, Ho CL, Kuo YH, Yip Y, Chao AN. Retinal toxicity of intravitreal tissue plasminogen activator: case report and literature review. Ophthalmology. 2003;110(4):704–708
  8. Sakuma T, Inoue J, Mizota A, Tanaka M, Souri M, Ichinose A. Use of autologous plasmin during vitrectomy for diabetic maculopathy. Eur J Ophthalmol. 2006;16(1):138–140
  9. Sakuma T, Inoue J, Mizota A, Tanaka M, Souri M, Ichinose A. Efficacy of autologous plasmin for idiopathic macular hole surgery. Eur J Ophthalmol. 2005;15(6):787–794
  10. Sakuma T, Tanaka M, Souri M, Ichinose A. Preparation of high-purity and safe autologous plasmin and its clinical application. Nippon Ganka Gakkai Zasshi. 2003;107(11):709–718
  11. Chen SD, Sundaram V, Lochhead J, Patel CK. Intravitreal triamcinolone for the treatment of ischemic macular edema associated with branch retinal vein occlusion. Am J Ophthalmol. 2006;141(5):876–883
  12. The Branch Vein Occlusion Study Group. Argon laser photocoagulation for macular edema in branch vein occlusion. Am J Ophthalmol. 1984;98(3):271–282
  13. The Central Vein Occlusion Study Group. Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion: the central vein occlusion study group M report. Ophthalmology. 1995;102(10):1425–1433
  14. Shilling JS, Jones CA. Retinal branch vein occlusion a study of argon laser photocoagulation in the treatment of macular edema. Br J Ophthalmol. 1984;68(3):196–198
  15. Chen SD, Lochhead J, Patel CK, Frith P. Intravitreal triamcinolone acetonide for ischaemic macular edema caused by branch retinal vein occlusion. Br J Ophthalmol. 2004;88(1):154–155
  16. Jonas JB, Akkoyun I, Kamppeter B, Kreissg I, Degenring RF. Branch retinal vein occlusion treated by intravitreal triamcinolone acetonide. Eye. 2005;19(1):65–71
  17. Young S, Larkin G, Branley M, Lightman S. Safety and efficacy of intravitreal triamcinolone for cystoid macular edema in uveitis. Clin Experimental Ophthalmol. 2001;29(1):2–6
  18. Jonas JB, Kreissig I, Degenring R. Intraocular pressure after intravitreal injection of triamcinolone acetonide. Br J Ophthalmol. 2003;87(1):24–27
  19. Degenring RF, Kamppeter B, Kreissig I, Jonas JB. Morphological and functional changes after intravitreal triamcinolone acetonide for retinal vein occlusion. Acta Ophthalmol Scand. 2003;81(5):548–550
  20. Wilson CA, Berkowitz BA, Sato Y, Ando N, Handa JT, de Juan E. Treatment with intravitreal steroid reduces blood-retinal barrier breakdown due to retinal photocoagulation. Arch Ophthalmol. 1992;110(8):1155–1159
  21. Sebag J. The Vitreous (Structure, Function, Pathobiology). New York: Springer Verlag; 1989;
  22. Tanaka M, Qui H. Pharmacological vitrectomy. Semin Ophthalmol. 2000;15(1):51–61
  23. Sebag J. Pharmacologic vitreolysis [editorial]. Retina. 1998;18(1):1–3
  24. Trese MT. Enzymatic-assisted vitrectomy. Eye. 2002;16(4):365–368
  25. Gandorfer A, Ulbig M, Kampik A. Plasmin-assisted vitrectomy eliminates cortical vitreous remnants. Eye. 2002;16(1):95–97
  26. Verstraeten TC, Chapman C, Hartzer M, Winkler BS, Trese MT, Williams GA. Pharmacologic induction of posterior vitreous detachment in the rabbit. Arch Ophthalmol. 1993;111(6):849–854
  27. Gandorfer A, Putz E, Welge-lussen U, Gruterich M, Ulbig M, Kampik A. Ultrastructure of the vitreoretinal interface following plasmin assisted vitrectomy. Br J Ophthalmol. 2001;85(1):6–10
  28. Gandorfer A, Pringlinger S, Schebitz K, et al. Vitreoretinal morphology of plasmin treated human eyes. Am J Ophthalmol. 2002;133(1):156–159
  29. Trese MT, Williams GA, Hartzer MK. A new approach to stage 3 macular holes. Ophthalmology. 2000;107(8):1607–1611
  30. Margherio AR, Margherio RR, Hartzer M, Trese MT, Williams GA, Ferrone PJ. Plasmin enzyme-assisted vitrectomy in traumatic pediatric macular holes. Ophthalmology. 1998;105(9):1617–1620
  31. Williams JG, Trese MT, Williams GA, Hartzer MK. Autologous plasmin enzyme in the surgical management of diabetic retinopathy. Ophthalmology. 2001;108(10):1902–1905
  32. Li X, Shi X, Fan J. Posterior vitreous detachment with plasmin in the isolated human eye. Graefes Arch Clin Exp Ophthalmol. 2002;240(1):56–62
  33. Hesse L, Nebeling B, Schroeder B, Heller G, Kroll P. Induction of posterior vitreous detachment in rabbits by intravitreal injection of tissue plasminogen activator following cryopexy. Exp Eye Res. 2000;70(1):31–39
  34. Kohno T, Sorgente N, Ishibashi T, Goodnight R, Ryan SJ. Immunofluorescent studies of fibronectin and laminin in the human eye. Invest Ophthalmol Vis Sci. 1987;28(3):506–514
  35. Quiram PA, Leverenz VR, Baker RM, Dang L, Giblin FJ, Trese MT. Microplasmin-induced posterior vitreous detachment affects vitreous oxygen levels. Retina. 2007;27(8):1090–1096

PII: S0002-9394(10)00429-0

doi: 10.1016/j.ajo.2010.06.005

American Journal of Ophthalmology
Volume 150, Issue 6 , Pages 876-882.e1 , December 2010